From Jan.2002 to Nov.2003, umbilical cord blood was collected, screened and processed at HCM City Blood Transfusion and Hematology Hospital for preparing to transplant. The Tokyo Umbilical Cord Blood Bank protocol of collecting, screening, processing and freezing were abided strictly, therefore, the obtained results were consistent with international literature. A stable procedure was established for the proper processus of UCB collection, screening and processing to meet the need of management of hereditary and malignant pathologies in Viet Nam
Fetal Blood ; Blood ; Cord Blood Stem Cell Transplantation

From Apr. 2001 to Nov. 2003, at HCM City Blood Transfusion and Hematology Hospital, study was performed to evaluate preliminarily the quality of stem cell preparation producted from umbilical blood cells after processed with CD34+ cells count , flown cytometry and with stem cell culture on methylcellulose medium. Results showed :the average CD34 stem cell count after processing in umbilical cord blood bag 1,94+/-1,05x1000 000 In 1ml cell culture : BFU- E:0,25x 1000 /ml, CFU-GM:6,75x 1000 /ml, CFU-Mix:8,55x1000 /ml
Cord Blood Stem Cell Transplantation ; Blood ; Cells

From 1990 to 2000, 513 cases of aplastic anemia were diagnosed and treated in Blood transfusion and Hematology Centre of Ho Chi Minh city, composing of 144 children and 369 adults with 279 males and 234 females. By bone marrow aspiration and biopsy, we diagnosed these cases as follow: aplastic anemia 449 cases (87.5%), hypocellularity of bone marrow: 45 (8.8%), one lignea hypocellularity of bone marrow: 19 (3.7%). From these cases, we have found that: - ’s difficult to point out accurately the cause of aplastic anemia and this is still the question for many studies in future. - All the patient was treated mainly blood transfusion, corticoid and androgen (77.5%) with complete and partial response was 25.5%. Besides, 32 cases were treated with corticoid + Sandimum given better results with complete response (32.7%).
Bone Marrow Diseases ; therapeutics

This 29 years old woman was admitted to the hospital with menstrual and dental bleeding. Physical examination revealed a pale brust on the legs. Laboratory data. - Hemograme: Hb: 7.5 g/dl, Hct: 22.7%, RBC: 2.86 x 1012/ l, WBC: 57.109/l hemostatic: PT: 23“7 (10”9), INR 5.86, aPTT: 32” (38”), PT¬mix 11”2 (10”9). Dosage of factor VII: 2.7%. Dosage of factor X: 102%. Diagnosis: congenital factor VII deficiency. Treatment: frozen plasma (15 ml/kg/day x 3 days) and provera 10 mg/dayx 4 days.
Congenital ; Factor VII Deficiency

From Feb 1997 to Feb 1998, 74 children with ITP, that diagnosed and treated for the first time (38 cas males, 36 cas females) at Centre of Blood Transfussion and Hematology, HCM City. Results of the treatment regimens corticosteroids 4mg/kg body weight/day and corticosteroids 2mg/kg body weight/day are noted: complete response (74.2%) partial response (9%), dependent of Corticosteroids (6.2%), persisstent thrombocytopenia (10.6%) and persistent ITP after 6 months (chronic ITP): 20.2%. With the treatment regimen 4mg/kg body weight/day, platelet counts increased to > 50.10 g/l in a median of 4+/- 0.85 days and the treatment regiment 2 mg/kg body weight/day, platelet counts incresed to > 50.10g/l in a median of 10+/- days (P< 0.001).
Purpura, Thrombocytopenic, Idiopathic ; Therapeutics ; Child

Objective: The purpose of this survey was to estimate the prevalence of viral load (VL) suppression and emergence of HIV drug resistance (HIVDR) among individuals receiving antiretroviral therapy (ART) for 36 months or longer in Viet Nam using a nationally representative sampling method. Methods: The survey was conducted between May and August 2014 using a two-stage cluster design. Sixteen ART clinics were selected using probability proportional to proxy size sampling, and patients receiving ART for at least 36 months were consecutively enrolled. Epidemiological information and blood specimens were collected for HIV-1 VL and HIVDR testing; HIVDR was defined by the Stanford University HIVDR algorithm. Results: Overall, 365 eligible individuals were recruited with a mean age of 38.2 years; 68.4% were men. The mean time on ART was 75.5 months (95% confidence interval [CI]: 69.0–81.9 months), and 93.7% of the patients were receiving non-nucleoside reverse transcriptase inhibitor-based regimens. Of the 365 individuals, 345 (94.7%, 95% CI: 64.1–99.4%) had VL below 1000 copies/mL and 19 (4.6%, 95% CI: 2.8-–7.5) had HIVDR mutations. Discussion Our nationally representative survey found a high level of VL suppression and a low prevalence of HIVDR among individuals who received ART for at least 36 months in Viet Nam. Continued surveillance for HIVDR is important for evaluating and improving HIV programs.

This article describes Viet Nam Ministry of Health’s (VMoH) activities to prepare for and respond to the threat Zika virus (ZIKV), including the adaptation of existing surveillance systems to encompass ZIKV surveillance.